Sorbax Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.05 Cr
- Satisfied Charges ₹ 4.04 Cr
- Revenue Growth 11661.87%
- Profit Growth 108.11%
- Ebitda 666.76%
- Net Worth 171.45%
- Total Assets 78.09%
About Sorbax Pharmaceuticals
Sorbax Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 2020 (Four years and three months 17 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.05 Cr. The company has closed loans amounting to ₹4.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Lalan Singh, Kota Prabhu, Dheeraj Shetty, and One other member serve as directors at the Company.
Company Details
-
Location
Solan, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290HP2020PTC008140
-
Company No.
008140
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Oct 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Sorbax Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalan Singh
|
Director | 15-Oct-2020 | Current |
|
Kota Prabhu
|
Director | 15-Oct-2020 | Current |
|
Dheeraj Shetty
|
Director | 24-Feb-2021 | Current |
|
Manjeet Kaur
|
Additional Director | 04-May-2024 | Current |
Financial Performance of Sorbax Pharmaceuticals.
Sorbax Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11661.87% increase. The company also saw a substantial improvement in profitability, with a 108.11% increase in profit. The company's net worth Soared by an impressive increase of 171.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sorbax Pharmaceuticals?
Unlock access to Sorbax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Chimes Life Sciences Private LimitedKota Prabhu is a mutual person
-
Jpd Pharmaceutical Private Limited
Dheeraj Shetty is a mutual person
Charges (Loans)
₹5.05 Cr
₹4.04 Cr
Charges Breakdown by Lending Institutions
- Others : 5.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2023 | Others | ₹5.05 Cr | Open |
| 13 Jul 2021 | Karnataka Bank Ltd. | ₹4.04 Cr | Satisfied |
How Many Employees Work at Sorbax Pharmaceuticals?
Unlock and access historical data on people associated with Sorbax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sorbax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sorbax Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
